tetramethylrhodamine iodoacetamide has been researched along with Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldwin, RW; Berry, N; Byers, VS; Durrant, L; Garnett, MC; Pawlucyzk, I; Pawluczyk, I; Price, MR; Robins, RA | 1 |
1 other study(ies) available for tetramethylrhodamine iodoacetamide and Carcinoma
Article | Year |
---|---|
Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Antigen-Antibody Reactions; Binding Sites, Antibody; Carcinoembryonic Antigen; Carcinoma; Cell Line; Cytotoxicity, Immunologic; Endocytosis; Epitopes; Humans; Immunotoxins; Mice; Rhodamines; Ricin; Serum Albumin; Stomach Neoplasms | 1988 |